BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16424874)

  • 21. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.
    Iqbal Z
    Asian Pac J Cancer Prev; 2014; 15(8):3541-6. PubMed ID: 24870754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report.
    Park JE; Park IJ; Lim YA; Lee WG; Cho SR
    Ann Clin Lab Sci; 2013; 43(2):186-9. PubMed ID: 23694795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1.
    Rothman R; Trakhtenbrot L; Bielorai B; Izraeli S; Ishoev G; Amariglio N; Rechavi G; Toren A
    Br J Haematol; 2005 May; 129(4):491-8. PubMed ID: 15877731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
    Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
    Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
    Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
    Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
    Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
    Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
    Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
    Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.
    Gandemer V; Rio AG; de Tayrac M; Sibut V; Mottier S; Ly Sunnaram B; Henry C; Monnier A; Berthou C; Le Gall E; Le Treut A; Schmitt C; Le Gall JY; Mosser J; Galibert MD
    BMC Genomics; 2007 Oct; 8():385. PubMed ID: 17956600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients.
    Brassesco MS; Camparoto ML; Tone LG; Sakamoto-Hojo ET
    Cytogenet Genome Res; 2004; 104(1-4):346-51. PubMed ID: 15162063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases.
    Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J
    Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
    Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
    Kanerva J; Niini T; Vettenranta K; Riikonen P; Mäkipernaa A; Karhu R; Knuutila S; Saarinen-Pihkala UM
    Med Pediatr Oncol; 2001 Nov; 37(5):419-25. PubMed ID: 11745869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
    McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Guo W; Loh ML; Smith MT
    Genes Chromosomes Cancer; 2003 May; 37(1):36-43. PubMed ID: 12661004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preleukemic TEL-AML1-positive clones at cell level of 10(-3) to 10(-4) do not persist into adulthood.
    Olsen M; Madsen HO; Hjalgrim H; Gregers J; Rostgaard K; Schmiegelow K
    J Pediatr Hematol Oncol; 2006 Nov; 28(11):734-40. PubMed ID: 17114960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.